C
Csaba P. Kovesdy
Researcher at University of Tennessee Health Science Center
Publications - 649
Citations - 41377
Csaba P. Kovesdy is an academic researcher from University of Tennessee Health Science Center. The author has contributed to research in topics: Kidney disease & Dialysis. The author has an hindex of 92, co-authored 605 publications receiving 31462 citations. Previous affiliations of Csaba P. Kovesdy include University of California, Irvine & Semmelweis University.
Papers
More filters
Journal ArticleDOI
Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study
Luis M. Ruilope,Bertram Pitt,Stefan D. Anker,Peter Rossing,Csaba P. Kovesdy,Roberto Pecoits-Filho,Pablo E. Pergola,Amer Joseph,Andrea Lage,Nicole Mentenich,Markus F. Scheerer,George L. Bakris +11 more
TL;DR: Finerenone protects against kidney disease progression and cardiovascular events in patients with T2D and early- or late-stage CKD and improvements in UACR, eGFR slope and cardiovascular risk were evident in both subgroups with finerenone.
Journal ArticleDOI
Obesity and kidney disease: hidden consequences of the epidemic
TL;DR: The World Kidney Day Steering Committee is made up of Philip Kam Tao Li, Guillermo Garcia-Garcia, Mohammed Benghanem-Gharbi, Rik Bollaert, Sophie Dupuis, Timur Erk, Kamyar Kalantar-Zadeh, Csaba Kovesdy, Charlotte Osafo and Elena Zakharova.
Journal ArticleDOI
Obesity and kidney disease: hidden consequences of the epidemic
TL;DR: The World Kidney Day Steering Committee aims to promote awareness of kidney disease and raise funds to support research and awareness of the disease and provide support to those affected by it.
Journal ArticleDOI
Traditional and novel dietary interventions for preventing progression of chronic kidney disease.
TL;DR: This article reviews the various interventions using such a strategy to prevent or slow the progression of CKD, with special focus on recent advances in this field.
Journal ArticleDOI
Donor hepatitis C antibody positivity misclassifies kidney donor profile index in non-hepatitis C-infected donors: time to revise the kidney donor profile index - a retrospective cohort study.
Masahiko Yazawa,Masahiko Yazawa,Masahiko Yazawa,Vasanthi Balaraman,Vasanthi Balaraman,Makoto Tsujita,Makoto Tsujita,Ambreen Azhar,Ambreen Azhar,Manish Talwar,Manish Talwar,Anshul Bhalla,Anshul Bhalla,Praveen K. Potukuchi,James D. Eason,James D. Eason,Csaba P. Kovesdy,Csaba P. Kovesdy,Miklos Z. Molnar +18 more
TL;DR: Recipients who receivedHCV Ab positive, but NAT‐negative donor kidneys did not experience worse 6‐month eGFR than correctly matched HCV Ab−/NAT− recipients, according to combined exact matching and propensity score matching.